Compare Suncor Energy Inc. (SU) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suncor Energy Inc. vs TG Therapeutics Inc — how do they compare? Suncor Energy Inc. trades at $72.18 (market cap $82.76B), while TG Therapeutics Inc trades at $55.14 (market cap $8.16B). The key difference: Suncor Energy Inc. is far larger — about 10.1× TG Therapeutics Inc's market cap, and Suncor Energy Inc. pays a 2.39% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Suncor Energy Inc. for 57 Days and TG Therapeutics Inc for 16 Days on average.
| SU | TGTX | |
|---|---|---|
Market Cap | $82.76B | $8.16B |
Volume | 3,832,959 | 1,735,121 |
Sector | Energy | Health |
52-Week High | $71.87 | $59.06 |
52-Week Low | $38.17 | $26.94 |
Typical Hold Time | 57 Days | 16 Days |
Enterprise Value | $89.29B | $8.37B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Suncor Energy (SU) trades at $72.23, up 6.0% today and near its 52-week high, reflecting strong momentum. The stock shows bullish technical signals with moving averages supporting further upside, while fundamentals indicate solid profitability with a 14.7% net income margin and attractive valuation at a P/E of 13.46. Recent Q2 2026 earnings beat expectations, and the company is boosting shareholder returns through buybacks and a $0.60 dividend.
The outlook remains positive given robust cash flow, debt reduction, and strategic asset sales, but risks include commodity price volatility and operational disruptions. With 74% analyst buy ratings and institutional confidence, SU offers value in the energy sector, though investors should monitor execution under new leadership and macroeconomic pressures.
TG Therapeutics (TGTX) trades at $54.80, up 3.49% today, but faces a bearish technical signal with recent earnings misses. Revenue growth is strong, with 2026 guidance raised to $950M for BRIUMVI, and net income margins exceed 55%. However, cash flow was negative in 2025, and a shareholder litigation investigation adds near-term uncertainty.
The outlook is mixed: analyst consensus is bullish with an $80.50 price target, but execution risks and earnings volatility persist. Upside hinges on BRIUMVI market share gains and subcutaneous formulation progress, while legal and competitive pressures pose threats to shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
